Ribonucleoside-diphosphate reductase large subunit — Drug Target

All drugs that target Ribonucleoside-diphosphate reductase large subunit — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nucleoside Metabolic Inhibitor [EPC]

Marketed (1)

• Clolar · Sanofi · Nucleoside Metabolic Inhibitor [EPC] · Oncology
  Clolar works by inhibiting the enzyme responsible for DNA synthesis, thereby preventing cancer cells from reproducing.